Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1832 4
1833 2
1841 1
1842 1
1843 1
1844 1
1846 1
1849 1
1852 1
1859 1
1866 4
1898 3
1899 2
1902 2
1903 2
1905 3
1906 2
1908 1
1910 2
1913 1
1917 1
1921 1
1922 2
1924 3
1925 1
1926 2
1927 1
1929 3
1931 1
1932 2
1933 1
1935 1
1936 1
1937 1
1939 2
1940 3
1941 3
1942 4
1943 6
1944 3
1945 4
1946 24
1947 16
1948 9
1949 10
1950 11
1951 12
1952 8
1953 13
1954 12
1955 10
1956 11
1957 19
1958 18
1959 18
1960 33
1961 22
1962 14
1963 23
1964 23
1965 19
1966 26
1967 30
1968 36
1969 34
1970 39
1971 57
1972 51
1973 55
1974 52
1975 36
1976 50
1977 51
1978 63
1979 65
1980 52
1981 66
1982 68
1983 77
1984 75
1985 81
1986 80
1987 98
1988 83
1989 86
1990 123
1991 92
1992 106
1993 119
1994 135
1995 126
1996 137
1997 123
1998 123
1999 150
2000 150
2001 171
2002 163
2003 168
2004 191
2005 211
2006 263
2007 258
2008 263
2009 293
2010 288
2011 341
2012 389
2013 365
2014 362
2015 387
2016 448
2017 468
2018 470
2019 429
2020 410
2021 488
2022 439
2023 410
2024 420
2025 396

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,751 results

Results by year

Filters applied: . Clear all
Page 1
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.
Rosen LE, Tortorici MA, De Marco A, Pinto D, Foreman WB, Taylor AL, Park YJ, Bohan D, Rietz T, Errico JM, Hauser K, Dang HV, Chartron JW, Giurdanella M, Cusumano G, Saliba C, Zatta F, Sprouse KR, Addetia A, Zepeda SK, Brown J, Lee J, Dellota E Jr, Rajesh A, Noack J, Tao Q, DaCosta Y, Tsu B, Acosta R, Subramanian S, de Melo GD, Kergoat L, Zhang I, Liu Z, Guarino B, Schmid MA, Schnell G, Miller JL, Lempp FA, Czudnochowski N, Cameroni E, Whelan SPJ, Bourhy H, Purcell LA, Benigni F, di Iulio J, Pizzuto MS, Lanzavecchia A, Telenti A, Snell G, Corti D, Veesler D, Starr TN. Rosen LE, et al. Among authors: taylor al. Cell. 2024 Dec 12;187(25):7196-7213.e26. doi: 10.1016/j.cell.2024.09.026. Epub 2024 Oct 8. Cell. 2024. PMID: 39383863 Free PMC article.
PARP inhibitors in metastatic prostate cancer.
Taylor AK, Kosoff D, Emamekhoo H, Lang JM, Kyriakopoulos CE. Taylor AK, et al. Front Oncol. 2023 Apr 24;13:1159557. doi: 10.3389/fonc.2023.1159557. eCollection 2023. Front Oncol. 2023. PMID: 37168382 Free PMC article. Review.
Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study.
Reel PS, Reel S, van Kralingen JC, Langton K, Lang K, Erlic Z, Larsen CK, Amar L, Pamporaki C, Mulatero P, Blanchard A, Kabat M, Robertson S, MacKenzie SM, Taylor AE, Peitzsch M, Ceccato F, Scaroni C, Reincke M, Kroiss M, Dennedy MC, Pecori A, Monticone S, Deinum J, Rossi GP, Lenzini L, McClure JD, Nind T, Riddell A, Stell A, Cole C, Sudano I, Prehn C, Adamski J, Gimenez-Roqueplo AP, Assié G, Arlt W, Beuschlein F, Eisenhofer G, Davies E, Zennaro MC, Jefferson E. Reel PS, et al. Among authors: taylor ae. EBioMedicine. 2022 Oct;84:104276. doi: 10.1016/j.ebiom.2022.104276. Epub 2022 Sep 27. EBioMedicine. 2022. PMID: 36179553 Free PMC article.
Effects of dietary and physical activity interventions on generic and cancer-specific health-related quality of life, anxiety, and depression in colorectal cancer survivors: a randomized controlled trial.
Ho M, Ho JWC, Fong DYT, Lee CF, Macfarlane DJ, Cerin E, Lee AM, Leung S, Chan WYY, Leung IPF, Lam SHS, Chu N, Taylor AJ, Cheng KK. Ho M, et al. Among authors: taylor aj. J Cancer Surviv. 2020 Aug;14(4):424-433. doi: 10.1007/s11764-020-00864-0. Epub 2020 Feb 18. J Cancer Surviv. 2020. PMID: 32072434 Free PMC article. Clinical Trial.
Oncogene-like addiction to aneuploidy in human cancers.
Girish V, Lakhani AA, Thompson SL, Scaduto CM, Brown LM, Hagenson RA, Sausville EL, Mendelson BE, Kandikuppa PK, Lukow DA, Yuan ML, Stevens EC, Lee SN, Schukken KM, Akalu SM, Vasudevan A, Zou C, Salovska B, Li W, Smith JC, Taylor AM, Martienssen RA, Liu Y, Sun R, Sheltzer JM. Girish V, et al. Among authors: taylor am. Science. 2023 Aug 25;381(6660):eadg4521. doi: 10.1126/science.adg4521. Epub 2023 Aug 25. Science. 2023. PMID: 37410869 Free PMC article.
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Rischin D, Porceddu S, Day F, Brungs DP, Christie H, Jackson JE, Stein BN, Su YB, Ladwa R, Adams G, Bowyer SE, Otty Z, Yamazaki N, Bossi P, Challapalli A, Hauschild A, Lim AM, Patel VA, Walker JL, De Liz Vassen Schurmann M, Queirolo P, Cañueto J, Ferreira da Silva FA, Stratigos A, Guminski A, Lin C, Damian F, Flatz L, Taylor AE, Carr DR, Harris S, Kirtbaya D, Quereux G, Rutkowski P, Basset-Seguin N, Khushalani NI, Robert C, Ju H, Joseph C, Bansal S, Chen CI, Seebach F, Yoo SY, Lowy I, Goncalves P, Fury MG; C-POST Trial Investigators. Rischin D, et al. Among authors: taylor ae. N Engl J Med. 2025 Aug 21;393(8):774-785. doi: 10.1056/NEJMoa2502449. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454639 Clinical Trial.
10,751 results
You have reached the last available page of results. Please see the User Guide for more information.